Insider Trading & Ownership of Jon Faiz Kayyem

Location
Carlsbad, CA
Summary
The estimated net worth of Jon Faiz Kayyem is at least $15,049,695 dollars as of 06 Jan 2026. Jon Faiz Kayyem is the Director of Inhibrx Biosciences, Inc. and owns shares of Inhibrx Biosciences, Inc. (INBX) stock worth about $15.03M. Jon Faiz Kayyem is the Director of BIODESIX INC and owns shares of BIODESIX INC (BDSX) stock worth about $19.6K.
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Jon Faiz Kayyem
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jon Faiz Kayyem and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Jon Faiz Kayyem has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $15,049,695.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Inhibrx Biosciences, Inc. ($15,030,087).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jon Faiz Kayyem

BDSX Forms 3/4/5

BIODESIX INC

Relationship
Director
Holdings value
$19,608
Past year net change
Change %
Report period
02 Jan 2026
INBX Forms 3/4/5

Inhibrx, Inc.

Relationship
Director
Holdings value
$0
Past year net change
Change %
Report period
30 May 2024

Insider Transactions Reported by Jon Faiz Kayyem:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .